Clinical trial
18FDG- PET/CT Contribution to the Assessment of Lesion Severity in Cystic…
NCT00363402 · Hadassah Medical Organization, Other · Completed
Key facts
| NCT number | NCT00363402 |
|---|---|
| Title | 18FDG- PET/CT Contribution to the Assessment of Lesion Severity in Cystic Fibrosis (CF) |
| Official title | 18FDG- PET/CT Contribution to the Assessment of Lesion Severity in Cystic Fibrosis (CF |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Procedure |
| Interventions | PET-CT |
| Enrollment | 20 |
| Start date | Aug 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Aug 15, 2006 |
| Last update posted | May 20, 2009 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: